
Morten A. Karsdal
Herlev, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 630 publications
Collagen turnover biomarkers as diagnostic, prognostic, and therapy monitoring indicators in gastric cancer.
Journal: Cancer biomarkers : section A of Disease markers
Published: August 21, 2026
Combination therapy of RAS inhibition and glucagon-like peptide-1 receptor agonist improves a marker of kidney fibrosis in people with type 2 diabetes.
Journal: American journal of physiology. Cell physiology
Published: August 17, 2026
Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the JAK2V617F Variant Allele Frequency in Myeloproliferative Neoplasms.
Journal: Cancers
Published: July 10, 2026
Erratum to 'Hot and cold fibrosis: The role of serum biomarkers to assess immune mechanisms and ECM-cell interactions in human fibrosis' [J Hepatol 83 (2025) 239-257].
Journal: Journal of hepatology
Published: April 28, 2026
Fibroblast activity biomarkers are associated with mortality in severe COVID-19: a post-hoc analysis of a phase 2 clinical trial.
Journal: Respiratory research
Published: March 25, 2026
Investigation of non-invasive tests for fibrosis diagnosis and prognostication of events in metabolic dysfunction-associated steatotic liver disease: A prospective study cohort.
Journal: Annals of hepatology
Published: February 27, 2026
Extracellular matrix proteins as risk markers for complications in type 1 diabetes.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: February 12, 2026
Extracellular matrix biomarkers of T-cell infiltration and tumor fibrosis predict response to nivolumab ± ipilimumab with SBRT in biliary tract cancer: insights from the CheckPAC trial.
Journal: BMC medicine
Published: February 04, 2026
Clinical comorbidity phenotypes in COPD and their biomarker signatures.
Journal: ERJ open research
Published: January 23, 2026
Increased remodeling of type XXII collagen is associated with an inflammatory phenotype in Crohn's disease.
Journal: Scientific reports
Published: January 16, 2026
Dual amylin and calcitonin receptor agonists as multifaceted disease-modifying osteoarthritis drugs.
Dual amylin and calcitonin receptor agonists as multifaceted disease-modifying osteoarthritis drugs.
Journal: International journal of obesity (2005)
Published: January 07, 2026
Investigating predictors of pain events during trials of knee osteoarthritis: A post-hoc analysis of two phase III trials.
Journal: Osteoarthritis and cartilage open
Published: January 05, 2026
Last Updated: 09/26/2026